Kesimpta (ofatumumab) pregnancy and infant safety study using real world data

First published 18/09/2023

Last updated 26/07/2024

EU PAS number:

EUPAS106133

Study

Ongoing

Download as PDF

Documents

Study protocol

Initial protocol

OMB157G2405 - V1.0 --protocol_Redacted

English (1.99 MB - PDF) View document

Study results

No information provided.

Study report

No information provided.

ENCePP Seal

The use of the ENCePP Seal has been discontinued since February 2025. The ENCePP Seal fields are retained in the display mode for transparency but are no longer maintained.

No information provided.

Kesimpta (ofatumumab) pregnancy and infant safety study using real world data

Secondary tabs

Share this page